PTC Therapeutics, Inc. (PTCT) Profit Margins
Over the twelve months to 2026-06-30, PTC Therapeutics, Inc. (PTCT) had operating margin 12.5%, net margin -3.8%, free cash flow margin -3.9%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PTCTPTC Therapeutics, Inc.Follow PTCT — free
—
Price chart with a free account
- Market cap
- 5.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 4 days
| Line | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | 97.6% | 95.2% | 96.0% | — | — | 75.9% | 59.7% | 66.0% | 96.5% | — | |
| Operating margin | -130.8% | -393.8% | -454.6% | -159.7% | -33.1% | -43.7% | -78.6% | -113.4% | -69.5% | -64.0% | -46.9% | -37.5% | 50.1% | 12.5% | |
| Net margin | -148.6% | -371.4% | -463.6% | -171.8% | -40.6% | -48.4% | -82.0% | -115.1% | -97.3% | -80.0% | -66.8% | -45.0% | 39.4% | -3.8% | |
| FCF margin | -137.7% | -245.3% | -345.6% | -127.4% | -6.8% | -13.1% | -36.6% | -55.7% | -51.9% | -55.6% | -19.9% | -14.2% | 40.6% | -3.9% |
USD billions · SEC XBRL
PTC Therapeutics, Inc. — questions
- What is PTC Therapeutics, Inc.'s operating margin?
- 12.5% over the twelve months to 2026-06-30.
- What is PTC Therapeutics, Inc.'s net profit margin?
- -3.8% over the twelve months to 2026-06-30.
Every figure on this page comes from PTC Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.